Affordability Boards: The States’ New Fix for Drug Pricing

381 New England Journal of Medicine 1301, DOI: 10.1056/NEJMp1906010 (Oct. 3, 2019)

Arizona Legal Studies Discussion Paper No. 19-21

Posted: 9 Oct 2019

See all articles by Tara Sklar

Tara Sklar

University of Arizona - James E. Rogers College of Law

Christopher T. Robertson

University of Arizona - James E. Rogers College of Law; Harvard University - Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

Date Written: October 3, 2019

Abstract

A new Maryland law that creates a prescription-drug affordability board to help the state regulate drug prices may be a harbinger of what’s to come in drug-pricing legislation. The law permits cost reviews when drug prices or price increases exceed specified thresholds. Establishing affordability boards may be a natural next step that more states take to exert a stronger influence over price spikes and still survive legal challenges.

Keywords: prescription drug crisis, price regulation, health care regulation

Suggested Citation

Sklar, Tara and Robertson, Christopher T., Affordability Boards: The States’ New Fix for Drug Pricing (October 3, 2019). 381 New England Journal of Medicine 1301, DOI: 10.1056/NEJMp1906010 (Oct. 3, 2019) ; Arizona Legal Studies Discussion Paper No. 19-21. Available at SSRN: https://ssrn.com/abstract=3465699

Tara Sklar (Contact Author)

University of Arizona - James E. Rogers College of Law ( email )

P.O. Box 210176
Tucson, AZ 85721-0176
United States

Christopher T. Robertson

University of Arizona - James E. Rogers College of Law ( email )

P.O. Box 210176
Tucson, AZ 85721-0176
United States

HOME PAGE: http://www.law.arizona.edu/faculty/getprofile.cfm?facultyid=714

Harvard University - Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics ( email )

23 Everett Street
Cambridge, MA 02155
United States

Register to save articles to
your library

Register

Paper statistics

Abstract Views
37
PlumX Metrics